Logo
A

Arcturus Therapeutics

191 employees

Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
mRNA medicine
Coronavirus
Vaccines
Development
Lipid-Mediated Delivery
COVID-19
Glycogen Storage disease
Partnerships
Genetics
OTC Deficiency
RNA
Rare Diseases
Cystic Fibrosis
Health Care
Discovery
Leadership
STARR
Therapeutics
Lipids
mRNA
HBV
Medical
Innovation
LUNAR

Date founded

2013

Funding rounds raised

Total raised

$115M

from 2 investors over 2 rounds

A

Arcturus Therapeutics raised $115M on August 14, 2023

Investors: Japan - The Government of Japan

A

Arcturus Therapeutics raised $63M on August 31, 2022

Investors: Biomedical Advanced Research and Development Authority (BARDA)

FAQ